Fermenta Biotech Intrinsic Value
Fermenta Biotech intrinsic value. Fermenta Biotech (FERMENTA) median intrinsic value is ₹586.08 from 10 valuation models (range ₹167–₹971), vs current price ₹557.45 — +5.1% upside (Trading Near Calculated Value), margin of safety 4.9%. For current market price and key ratios, visit Fermenta Biotech screener.
FERMENTA Valuation Methods Summary — DCF, Graham Number & P/E
Fermenta Biotech intrinsic value across 10 models vs current price ₹557.45 — upside/downside and value range per method. Compare with FERMENTA DCF valuation to assess whether the stock is under or overvalued.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹586.08 | ₹468.86 - ₹703.30 | +5.1% | EPS: ₹26.64, Sector P/E: 22x |
| Book Value Method | asset | ₹572.86 | ₹515.57 - ₹630.15 | +2.8% | Book Value/Share: ₹286.43, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹777.14 | ₹699.43 - ₹854.85 | +39.4% | Revenue/Share: ₹388.57, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹971.43 | ₹874.29 - ₹1068.57 | +74.3% | EBITDA: ₹136.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹902.32 | ₹721.86 - ₹1082.78 | +61.9% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹170.50 | ₹153.45 - ₹187.55 | -69.4% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹411.59 | ₹370.43 - ₹452.75 | -26.2% | Revenue Growth: 6.0%, Adj P/E: 15.5x |
| ROE Based Valuation | profitability | ₹760.00 | ₹684.00 - ₹836.00 | +36.3% | ROE: 19.0%, P/E Multiple: 14x |
| Graham Defensive Method | conservative | ₹414.35 | ₹372.92 - ₹455.79 | -25.7% | EPS: ₹26.64, BVPS: ₹286.43 |
| Dividend Yield Method | dividend | ₹167.24 | ₹150.52 - ₹183.96 | -70.0% | DPS: ₹3.75, Target Yield: 2.5% |
FERMENTA Intrinsic Value vs Market Price — All Valuation Models
Fermenta Biotech fair value range ₹167–₹971 vs current market price ₹557.45 across 10 valuation models. Read FERMENTA dividend history for the complete payout history and dividend yield track record.
FERMENTA Intrinsic Value Analysis — Undervalued or Overvalued?
Fermenta Biotech median intrinsic value ₹586.08, current price ₹557.45 — Trading Near Calculated Value by 5.1%, margin of safety 4.9%.
What is the intrinsic value of FERMENTA?
Based on our comprehensive analysis using 10 different valuation methods, the estimated intrinsic value of Fermenta Biotech (FERMENTA) is ₹586.08 (median value). With the current market price of ₹557.45, this represents a +5.1% variance from our estimated fair value.
The valuation range spans from ₹167.24 to ₹971.43, indicating ₹167.24 - ₹971.43.
Is FERMENTA undervalued or overvalued?
Based on our multi-method analysis, Fermenta Biotech (FERMENTA) appears to be trading near calculated value by approximately 5.1%.
FERMENTA Financial Health — Key Ratios vs Industry Benchmarks
Fermenta Biotech financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 9.95 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 19.0% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 16.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.84x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
FERMENTA Cash Flow Quality — Operating & Free Cash Flow
Fermenta Biotech operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹93 Cr | ₹72 Cr | Positive Free Cash Flow | 8/10 |
| March 2025 | ₹41 Cr | ₹41 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹105 Cr | ₹97 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹116 Cr | ₹89 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹43 Cr | ₹30 Cr | Positive Free Cash Flow | 8/10 |